Intra-Cellular Therapies Inc. buy JPMorgan Chase & Co.
Start price
09.03.23
/
50%
€41.80
Target price
09.03.24
€54.81
Performance (%)
45.22%
End price
10.03.24
€60.70
Summary
This prediction ended on 10.03.24 with a price of €60.70. With a performance of 45.22% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target lowered by analysts at JPMorgan Chase & Co. from $59.00 to $58.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€80.00
04.11.24
04.11.24
€81.61
04.11.25
04.11.25
53.75%
05.11.25
05.11.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.00
21.08.24
21.08.24
€72.78
21.08.25
21.08.25
80.88%
22.08.25
22.08.25
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
12.06.24
12.06.24
€72.03
12.06.25
12.06.25
92.19%
13.06.25
13.06.25